MET and breast cancer: In an orthotopic nude mouse model using the MDA-MB-231/GFP human breast cancer cell line, 5 mg/kg (-)-oleocanthal reduced tumor growth and inhibited tumor activation of c-Met, the proliferation marker Ki-67 and the expression of vessel formation marker CD31 [156].